These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

411 related items for PubMed ID: 14738656

  • 21. Sociodemographic factors of Pap smear screening in Taiwan.
    Wang PD, Lin RS.
    Public Health; 1996 Mar; 110(2):123-7. PubMed ID: 8901257
    [Abstract] [Full Text] [Related]

  • 22. The frequency of having pap-smear tests among women between 15-64 years old and the evaluation of the level of their knowledge.
    Sevil S, Kevser O, Aleattin U, Ozlem D.
    J Pak Med Assoc; 2013 Jul; 63(7):873-7. PubMed ID: 23901712
    [Abstract] [Full Text] [Related]

  • 23. Cervical cancer: how often--and why--to screen older women.
    Mandelblatt JS, Phillips RN.
    Geriatrics; 1996 Jun; 51(6):45-8; quiz 49. PubMed ID: 8647475
    [Abstract] [Full Text] [Related]

  • 24. The use of Pap smear and its influencing factors among women with disabilities in Taiwan.
    Huang KH, Tsai WC, Kung PT.
    Res Dev Disabil; 2012 Jun; 33(2):307-14. PubMed ID: 22100350
    [Abstract] [Full Text] [Related]

  • 25. Frequency of cervical cancer and breast cancer screening in HIV-infected women in a county-based HIV clinic in the Western United States.
    Rahangdale L, Sarnquist C, Yavari A, Blumenthal P, Israelski D.
    J Womens Health (Larchmt); 2010 Apr; 19(4):709-12. PubMed ID: 20201703
    [Abstract] [Full Text] [Related]

  • 26. Patterns of cervical cancer screening, diagnosis, and follow-up treatment in a state Medicaid fee-for-service population.
    Nadpara PA, Madhavan SS, Khanna R, Smith M, Miller LA.
    Popul Health Manag; 2012 Dec; 15(6):362-71. PubMed ID: 22788858
    [Abstract] [Full Text] [Related]

  • 27. Evaluation of cervical cancer screening program at a rural community of South Africa.
    Hoque M, Hoque E, Kader SB.
    East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
    [Abstract] [Full Text] [Related]

  • 28. Pap smear coverage among rural workers.
    London L.
    S Afr Med J; 1993 Mar; 83(3):172-6. PubMed ID: 8511683
    [Abstract] [Full Text] [Related]

  • 29. Factors associated with Pap smear screening among French women visiting a general practitioner in the Rhône-Alpes region.
    Oussaid N, Lutringer-Magnin D, Barone G, Haesebaert J, Lasset C.
    Rev Epidemiol Sante Publique; 2013 Oct; 61(5):437-45. PubMed ID: 24012357
    [Abstract] [Full Text] [Related]

  • 30. Risk of invasive cervical cancer after three consecutive negative Pap smears.
    Coldman A, Phillips N, Kan L, Matisic J, Benedet L, Towers L.
    J Med Screen; 2003 Oct; 10(4):196-200. PubMed ID: 14738657
    [Abstract] [Full Text] [Related]

  • 31. Is a liquid-based cytology more sensitive than a conventional Pap smear?
    Sigurdsson K.
    Cytopathology; 2013 Aug; 24(4):254-63. PubMed ID: 23331613
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.
    Branca M, Garbuglia AR, Benedetto A, Cappiello T, Leoncini L, Migliore G, Agarossi A, Syrjänen K, DIANAIDS Collaborative Study Group.
    Int J STD AIDS; 2003 Jun; 14(6):417-25. PubMed ID: 12816671
    [Abstract] [Full Text] [Related]

  • 35. Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America. This report refers to partial results from the LAMS (Latin AMerican Screening) study.
    Sarian LO, Derchain SF, Naud P, Roteli-Martins C, Longatto-Filho A, Tatti S, Branca M, Erzen M, Serpa-Hammes L, Matos J, Gontijo R, Bragança JF, Lima TP, Maeda MY, Lörincz A, Dores GB, Costa S, Syrjänen S, Syrjänen K.
    J Med Screen; 2005 Jun; 12(3):142-9. PubMed ID: 16156945
    [Abstract] [Full Text] [Related]

  • 36. Augmentation of Pap smear screening of high risk aboriginal women. Use of a computerised process tool within the Broome Aboriginal Medical Service.
    Couzos S, Wronski I, Murray R, Cox H.
    Aust Fam Physician; 1998 Apr; 27(4):269-74. PubMed ID: 9581335
    [Abstract] [Full Text] [Related]

  • 37. Pap smear utilization in Canada: estimates after adjusting the eligible population for hysterectomy status.
    Snider JA, Beauvais JE.
    Chronic Dis Can; 1998 Apr; 19(1):19-24. PubMed ID: 9550731
    [Abstract] [Full Text] [Related]

  • 38. Perceptions and concerns of women undergoing Pap smear examination in a tertiary care hospital of India.
    Tiwari A, Kishore J, Tiwari A.
    Indian J Cancer; 2011 Apr; 48(4):477-82. PubMed ID: 22293264
    [Abstract] [Full Text] [Related]

  • 39. Cervicography: adjunctive cervical cancer screening by primary care clinicians.
    Ferris DG, Payne P, Frisch LE, Milner FH, diPaola FM, Petry LJ.
    J Fam Pract; 1993 Aug; 37(2):158-64. PubMed ID: 8336097
    [Abstract] [Full Text] [Related]

  • 40. Cervical cancer screening among U.S. women: analyses of the 2000 National Health Interview Survey.
    Hewitt M, Devesa SS, Breen N.
    Prev Med; 2004 Aug; 39(2):270-8. PubMed ID: 15226035
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.